A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 110
- Population
- ALL · 70 Years to 99 Years
- Duration
- 2024-09-01 to 2026-02-01
- Intervention
- EDUcation; EXERcise; EDU-EXER; CONtrol
- Comparator
- CONtrol
- Outcomes measured
- Relative lower limbs muscle power — Change from Baseline STS muscle power at 12 weeks; Vital functional capacity — Change from Baseline Vital functional capacity at 12 weeks; Level of physical activity during the daily life — Change from Baseline Level of physical activity at 12 weeks; The quality of life (QoL) — Change from Baseline the quality of life at 12 weeks; Subjective health-status level — Change from Baseline the health status level at 12 weeks; Cognitive Function - Mini-mental state examination (MMSE) — Change from Baseline MMSE at 12 weeks; Cognitive Function - The Montreal cognitive assessment test (MoCA) — Change from Baseline MoCA at 12 weeks; Mood State - Geriatric Depression Scale (GDS) — Change from Baseline Geriatric Depression Scale (GDS) at 12 weeks; Nutritional profile measurements - Mediterranean Diet Adherence Screener index — Change from Baseline Nutritional profi…; Degree of frailty - Fried criteria — Change from Baseline frailty degree at 12 weeks; Body composition - Bioimpedance — Change from Baseline Bioimpedance composition at 12 weeks; Body composition - body mass index (BMI) — Change from Baseline body mass index (BMI) at 12 weeks; Body composition - height — Change from Baseline height at 12 weeks; Body composition - weight — Change from Baseline weight at 12 weeks; Musculoskeletal ultrasound architecture — Change from Baseline Musculoskeletal ultrasound architecture at 12 weeks; Depressive Symptoms — Change from Baseline Depressive Symptoms at 12 weeks
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.